Injunction on Trochanteric Fixation Nail (TFN) Revised
Synthes to divest Techron’s non-core business
Synthes with continued strong growth in third quarter 2006
German Federal Cartel Office clears Asset Purchase Agreement
Synthes, Inc. Announces First Half-Year 2006 Financial Results and FDA PMA approval for ProDisc® -L
H1 2006 Local Currency Sales and Net Earnings up 15.1% and 10.1%, respectively, versus the prior year
Synthes, Inc. Announces Strong First Quarter 2006 Sales Results: Q1 2006 Sales up 17.4% versus the prior year (in local currency)
Resolutions of the 2006 AGM
Synthes Statement Regarding Service of Subpoenas
Synthes and the AO Foundation agree to continue cooperation
Synthes, Inc. Today Announces Full Year 2005 Financial Results: 2005 Sales up 16.8%, net profit up 34.7% versus the prior year >more
Download Annual Report 2005 >more
Synthes receives an “Approvable Letter” from the United States Food and Drug Administration (FDA) regarding the ProDisc-L Lumbar Total Disc Replacement
